adipose tissues [2] . Eosinophil localization to these tissues is likely mediated by constitutively expressed eotaxin 1. Newly identified type-2 innate lymphoid cells (ILC2s) also likely play a role [3] . Eosinophils in these tissues may be involved in tissue morphogenesis and the maintenance of homeostasis. For example, they may prepare the mature uterus for pregnancy and blastocyst implantation [4] , and may be involved in postnatal mammary gland development [5] . In addition, they may maintain epithelial barrier integrity [6] and/or innate host defense in the gastrointestinal tract [7] . Eosinophils in white adipose tissues produce interleukin 4 (IL-4) and support alternatively activated macrophages, resulting in the maintenance of metabolic homeostasis and enhanced glucose tolerance [8] .
Another potential role for eosinophils under baseline conditions may be immune homeostasis. It has been suggested that, in the thymus, they are involved in major histocompatibility complex (MHC) class I-restricted thymocyte deletion [9] . Eosinophils have been associated with apoptotic bodies in MHC class I-restricted male antigen T cell receptor (TCR) transgenic mice injected with a cognate antigen. In bone marrow, eosinophils localize together with plasma cells and support the survival of the plasma cells by secreting a proliferation-inducing ligand (APRIL) and IL-6 [10] . Depletion of eosinophils induces apoptosis in long-lived bone marrow plasma cells. Altogether, this evidence suggests that the steady-state presence of eosinophils under baseline conditions may play a role in tissue and immune homeostasis in various organs. Further studies will be necessary to determine whether these observations in mice apply to humans.
Regulation of Immune Response and Tissue Condition by Eosinophils
Eosinophil Production of Immunoregulatory Molecules Eosinophils can perform various immune regulatory functions likely through two main mechanisms: the production of a range of immunomodulatory molecules and the presentation of antigens [11, 12] . Eosinophils produce cytokines, able to act on the eosinophils themselves, the so-called 'autocrine' cytokines, including IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) [13] . Other eosinophil-derived cytokines can influence tissue cells and other inflammatory cells. For example, eosinophil-derived transforming growth factor-β (TGF-β) enhances proliferation and collagen synthesis of lung and dermal fibroblasts [14] . TGF-α produced by cytokine-activated eosinophils increases mucin production by airway epithelial cells [15] . Other tissue growth factors, such as osteopontin, vascular endothelial cell growth factor (VEGF) and nerve growth factor (NGF), are also produced by eosinophils [16] . IL-4 protein has been localized to eosinophils in airway [17] and skin [18] tissue specimens from patients with allergic diseases. When stimulated with eotaxin 1 (CCL11) or RANTES (CCL5), human eosinophils rapidly release stored IL-4 by vesicular transport to the local milieu [19] . Several other cytokines and chemokines are also transcribed and/or produced by eosinophils, including IL-6, IL-10, tumor necrosis factor (TNF)-α and a variety of chemokines [12] .
Eosinophils and their products can affect the functions of immune cells independent of cytokines. Indoleamine 2,3-dioxygenase (IDO) is an enzyme that catalyzes the oxidative catabolism of tryptophan to kynurenines; kynurenines inhibit proliferation and promote preferential apoptosis of Th1 cells [20] . Human eosinophils from allergic donors constitutively express IDO [21] . Eosinophil-derived neurotoxin (EDN), an eosinophil granule protein, has potent immunomodulatory capacity. It is a chemoattractant [22] and activator [23] of dendritic cells (DCs). As a consequence, it enhances Th2 responses through a Toll-like receptor 2 (TLR2)-dependent mechanism [24] . Finally, eosinophils possess the ability to internalize, process and present antigenic peptides within the context of MHC class II. They also have the capacity to provide costimulatory signals to T cells through surface expression of molecules, such as CD80, CD86 and CD40 [25] . Indeed, antigen-pulsed eosinophils instilled intratracheally into recipient mice are sufficient for the expansion of Th2 cells within draining lymph nodes in vivo.
Tissue Remodeling and Immunoregulatory Functions of Eosinophils in vivo
The immunoregulatory functions of eosinophils are clearly demonstrated in murine models of allergen sensitization and challenge, exposure to natural allergens and helminth infection. An early wave of eosinophil influx into inflammation sites precedes that of lymphocytes [26, 27] and it occurs even in mice deficient in adaptive immunity [28, 29] . This 'innate' eosinophil infiltration is likely mediated by ILC2s that have the capacity to produce a large quantity of type 2 cytokines [27, 30] . Interestingly, in IL-5/eotaxin double-knockout mice, in which eosinophil numbers in both blood and tissues are severely decreased, IL-13 production by Th2 cells in response to antigen challenge is attenuated [31] , suggesting regula-tion of the adaptive Th2-type immune response by eosinophils.
There have been comparable findings in eosinophildeficient animals generated by genetic manipulation. A strategy to deplete eosinophils used an eosinophil-specific promoter that drives expression of a cytocidal protein, diphtheria toxin A chain (PHIL mice) [32] . Another strategy deleted a high-affinity GATA-binding site in the GATA-1 promoter (Δdbl-GATA), resulting in specific ablation of the eosinophil lineage [33] . When these mice were sensitized and challenged with ovalbumin antigen, Th2-type airway inflammation and asthma-like pathology (e.g. airway hyperreactivity and mucus production) were attenuated, and these responses were restored by reconstitution of eosinophils only [34] or a combination of eosinophils and antigen-specific T cells [35] . The deficiency in eosinophils resulted in the defect of airway chemokine responses [34, 35] , suggesting that eosinophils may be involved in the priming of the tissue environment for effective mobilization of Th2 cells. Human clinical studies have confirmed some aspects of these observations. For example, an improvement in airway remodeling was observed in asthma patients treated with anti-IL-5 [36] . Overall, eosinophils can provide a wide variety of growth factors, cytokines and chemokines, suggesting that they are potentially involved in diverse biological responses, from tissue remodeling to the activation of immune cells.
Eosinophil Proinflammatory and Cytotoxic Functions
Eosinophil Granule Proteins Traditionally, eosinophils are considered to be effector cells with proinflammatory and destructive capabilities. Human eosinophils contain several highly basic and cytotoxic granule proteins, including major basic protein (MBP), MBP2, eosinophil cationic protein (ECP), eosinophil peroxidase (EPX) and EDN. Human MBP is a highly basic and amphipathic protein rich in arginine [1] . Because human MBP binds to and disrupts the membrane of schistosomula, it directly damages Schistosoma mansoni [1] . MBP is also cytotoxic against other helminths and certain bacteria, such as Staphylococcus aureus and Escherichia coli . Human MBP is toxic to mammalian cells by disrupting the integrity of lipid bilayers [37] . Human ECP is another basic protein with an isoelectric point (pI) of 10.8 [1] . ECP possesses ribonuclease (RNase) activity and this is required for the neurotoxic properties of the protein. Human EDN is another RNase and a powerful neurotoxin that can severely damage myelinated neurons [1] . While EDN shows marked amino acid sequence homology (67%) with ECP, EDN has about 100 times more RNase activity than ECP. EDN shows significant toxicity against newborn larvae of Trichinella spiralis . Importantly, EDN as well as ECP have antiviral activities and decrease the infectivity of respiratory syncytial virus (RSV) dependent on their RNase activities [38] . In guinea pigs infected with parainfluenza, pretreatment with anti-IL-5 and a reduction of eosinophils markedly increased the viral content in the airways [39] . EPX is a member of a mammalian peroxidase family. It is a central participant in generating reactive oxidants and radical species by activated eosinophils [1] . EPX plus H 2 O 2 and halide (Cl -, Br -or I -) kills a variety of microorganisms.
Mechanisms of Eosinophil Activation
Extensive studies have been performed to elucidate the mechanisms by which eosinophils release these cytotoxic granule proteins and other inflammatory mediators. IL-3, IL-5 and GM-CSF, besides being important growth and maturation factors for eosinophils, stimulate the effector functions of mature human eosinophils [40] . Other Th2 cytokines, such as IL-4 and IL-13, also activate eosinophils [41] . A prototypic Th1 cytokine, interferon (IFN)-γ, activates eosinophils, but does so in a delayed manner [42] . More recently, the cytokines derived from the epithelium, such as IL-33 and thymic stromal lymphopoietin (TSLP), have been implicated in promoting Th2-type immune response [43] . Both TSLP [44] and IL-33 [45] activate eosinophil effector functions such as adhesion to matrix proteins, production of cytokines and degranulation. Interestingly, IL-33 does not affect neutrophil functions [45] , suggesting that it may regulate functions of eosinophils specifically in airway mucosa. Human eosinophils recognize a wide variety of products that are expressed or produced by microbes, resulting in cellular activation and the release of inflammatory mediators. For example, human eosinophils constitutively express TLR1, TLR4, TLR7, TLR9 and TLR10 messenger RNAs, and the TLR7 ligand, R-848, can activate eosinophils [46] .
Distinct Mechanisms of Eosinophil Activation
Although cellular activation induced by exposure to cytokines and TLR ligands is commonly observed in various types of inflammatory cells, eosinophils appear to have several unique, although perhaps not specific, properties. Proteolytic enzymes, which are produced by microbes and allergens, potently induce the activation and noncytotoxic degranulation of eosinophils. Proteases, especially serine proteases, activate hematologic and interstitial cells through a family of G-protein-coupled protease-activated receptors (PAR) and induce production of several proinflammatory mediators [47, 48] . Authentic proteases, such as trypsin and papain, potently induce human eosinophils to degranulate and produce superoxide anion [48] . Importantly, eosinophils are activated by a natural cysteine protease from mite allergens, Der f 1 [48] . Eosinophils also recognize the aspartate protease activity and cysteine protease activity that are produced by the fungus Alternaria alternata [49] and cockroaches [50] , respectively, through PAR-2. Thus, human eosinophils are equipped with mechanisms that recognize and respond to proteases, such as those found in microbes and at allergic response sites, resulting in the active release of proinflammatory mediators.
An association between fungal exposure and asthma has been widely recognized [51] , and the products of fungi may contribute to the development and exacerbation of allergic airway diseases. Indeed, extracts of the fungus Alternaria strongly activate eosinophils, resulting in degranulation, increases in intracellular calcium concentration, cell surface expression of CD63 and CD11b and production of IL-8 [52] . Interestingly, Alternaria does not induce neutrophil activation, suggesting specificity of the responding cell type. In addition, when human eosinophils are exposed to live A. alternata fungus, eosinophils release their cytotoxic granule proteins into the extracellular milieu and onto the surface of fungal organisms, killing the fungus in a contact-dependent manner [53] . Eosinophils use their versatile β2 integrin molecule, CD11b or Mac-1, to recognize and adhere to a major fungal cell wall component, β-glucan.
Eosinophil activation can be induced by other biological molecules. During tissue injury, endogenous molecules are released by stressed or damaged tissues, including uric acid, adenosine triphosphate (ATP), high mobility group box (HMGB)-1 and S100 calcium-binding protein family members [54] . Eosinophils are attracted to uric acid crystals, and produce a large quantity and various kinds of cytokines and chemokines [55] . The endogenous ATP produced by eosinophils themselves likely provides a positive feedback signal to eosinophils through a P2Y purinoreceptor, P2Y2. Similarly, HMGB-1 attracts eosinophils and enhances their survival in vitro [56] . Thus, eosinophils may recognize damaged tissues/cells, and thereby may contribute to attaining tissue homeostasis or modulating the inflammatory and immunological processes.
Roles for Cellular Adhesion
One of the unique and important biological characteristics of eosinophils is their ability to recognize organisms with a large surface. For example, initial studies of eosinophil degranulation in vitro used parasites as a model. Eosinophils incubated with the antiserum-coated schistosomula of S. mansoni degranulated and released MBP [1] . Furthermore, 'artificial parasites', namely Sepharose beads coated with immunoglobulin G (IgG), IgA and secretory IgA (sIgA), stimulated eosinophil degranulation [57] ; sIgA was the most effective of these immunoglobulins. Eosinophils possess a binding site(s) for the secretory component of secretory IgA [58] , and the interaction with the secretory component greatly enhanced the proinflammatory functions of eosinophils, but not of neutrophils [58] .
Notably, an integrin adhesion molecule, Mac-1 (CD11b/ CD18, αMβ2), likely plays pivotal roles in regulating eosinophil degranulation; this molecule is not only important for eosinophil migration but also crucial for eosinophil effector functions. Historically, as described above, receptor ligands immobilized to relatively large surfaces such as sIgA-coated Sepharose beads and parasites are potent and effective stimuli for eosinophil degranulation [57] . Later, it was found that β 2 integrins, especially Mac-1, play a crucial role in the activation of eosinophils stimulated by IgG when IgG is immobilized onto tissue-culture plates or Sepharose beads [59] . Similarly, the eosinophil functional response to PAF or GM-CSF is greatly influenced by the availability of cellular adhesion [60, 61] . When eosinophils are stimulated with these soluble mediators, they adhere to the tissue-culture wells through β2 integrins, and this adhesion process provides critical signals to amplify cellular activation and degranulation [62] . Conversely, when eosinophils are activated with sIgA but kept in suspension (i.e. without Sepharose beads), they produce cytokines such as GM-CSF and IL-8 but do not release granule proteins. Mac-1 is also used to recognize β-glucan on the surface of fungi and to release granule proteins [53] . Indeed, eosinophil granule release can be induced by the direct ligation of integrins by antibodies or ligands to Mac-1 [62] or VLA-4 [63] in the absence of additional stimuli. While the molecular mechanism to explain pronounced activation of eosinophils by cellular adhesion through β2 integrin is not fully understood, it likely involves other cell surface molecules that are physically associated with the integrin, such as a GPI-anchored protein, CD66b, and signaling molecules localized in lipid rafts [64] . Thus, β2 integrins, in particular CD11b/CD18, may play a pivotal role in determining the functional outcomes of human eosinophils that are exposed to immuno- logical and inflammatory stimuli. The ability of human eosinophils to effectively engage the integrins and to respond to microbes/molecules with a large surface likely makes this leukocyte distinct from other granulocytes.
Summary and Future Directions
Eosinophils have been considered as end-stage cells involved in host protection against parasite infection and immunopathology in Th2-type inflammation. However, recent studies have changed this perspective and eosinophils are now considered to be multifunctional leukocytes involved in tissue homeostasis, modulation of adaptive immune responses and innate immunity to certain microbes. However, such new information does not preclude that eosinophils, in particular human eosinophils, are also effector cells with proinflammatory and destructive capabilities. The damaging characteristics of eosinophil lipid mediators and granule proteins were well established in the 1990s. Eosinophils with activation phenotypes are observed in biological specimens from patients with disease, and deposition of eosinophil products is readily seen in the affected tissues from these patients. Therefore, it would be reasonable to consider the eosinophil a multifaceted leukocyte that contributes to various physiological and pathological processes, depending on its location and activation status ( fig. 1 ) .
Two major challenges in the field of eosinophil biology have been identified. First, mice have been used extensively and successfully to study the mechanisms of Th2-type inflammation in asthma and parasite infection and the roles of eosinophils in these disease models. However, significant differences exist between mice and humans in immune system development and activation [65] , and unfortunately, eosinophils are not exempt from these challenges. For example, mouse eosinophil-associated RNases are remarkably divergent (>50%) orthologs of human EDN and ECP [66] . In addition, among the various molecules involved in activation and effector functions of human eosinophils, as discussed above, FcαRI (IgA receptor), FcγRIIA and C (activating IgG receptor) and CD66b cannot be identified in the mouse genome. Indeed, mouse eosinophils shows a distinct response to cytokines and other agonists and have a limited propensity to degranulate in vitro [67, 68] . In mouse models of human diseases, therefore, we run the risk of overlooking aspects of human eosinophils that do not occur or cannot be reproducibly modeled.
The second challenge is that some functions of eosinophils most likely overlap with the effector functions of other immune cells (e.g. cytokine production by CD4 + T cells), and the role of eosinophils alone may be difficult to demonstrate in physiological settings. Furthermore, inflammation is a complex event involving both tissue damage and tissue repair/remodeling [69] . It would be difficult to discern the role of eosinophils if they are involved both in the damaging and repair processes. It would be impossible to categorize eosinophils simply as the 'good guy' or the 'bad guy'. Therefore, further studies will be necessary to answer critical questions concerning the true involvement of eosinophils in health and disease processes. This goal can be accomplished by integrated and multidisciplinary approaches including better characterization of the immunobiology of eosinophils and their products in vitro, careful analyses of animal models in vivo and more in-depth investigation of specimens from patients. Although this is a challenging task, future studies hold the promise of revealing the true importance of eosinophils in human health and disease.
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